Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40001875
Localisation
Switzerland
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
10/04/2025
Statut
Classification
1.5°C
Année cible
2033
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: Siegfried Holding commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Siegfried Holding commits to reduce absolute scope 1 and 2 GHG emissions 66.89% by 2033 from a 2020 base year. Siegfried Holding also commits that 85% of its suppliers by emissions covering purchased goods and services, will have science-based targets by 2029. Siegfried Holding further commits to reduce absolute scope 3 GHG emissions from fuel and energy related activities, upstream transportation and distribution, waste generated in operations 32.5% by 2033 from a 2022 base year. Long-Term Targets: Siegfried Holding commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2050 from a 2020 base year. Siegfried Holding also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, upstream transportation and distribution, waste generated in operations, processing of sold products and end of life treatment of sold products 90% by 2050 from a 2022 base year.
Statut
Targets setAnnée cible
2050
Statut
BA1.5 memberDate d'engagement
03/11/2022
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
CH0014284498
LEI
506700J9QD6IF3937W06
Source : Science Based Targets initiative | Données publiques